Updates are available Correction dated 2022-11-03
Click to view Correction: https://doi.org/10.1038/s41591-022-02091-9
-
Authors
Mackensen, Andreas http://orcid.org/0000-0002-0685-4483
Müller, Fabian
Mougiakakos, Dimitrios
Böltz, Sebastian http://orcid.org/0000-0001-5227-8707
Wilhelm, Artur http://orcid.org/0000-0002-4637-1582
Aigner, Michael
Völkl, Simon
Simon, David http://orcid.org/0000-0001-8310-7820
Kleyer, Arnd http://orcid.org/0000-0002-2026-7728
Munoz, Luis
Kretschmann, Sascha
Kharboutli, Soraya
Gary, Regina
Reimann, Hannah http://orcid.org/0000-0002-7336-2008
Rösler, Wolf
Uderhardt, Stefan
Bang, Holger
Herrmann, Martin http://orcid.org/0000-0002-0258-2484
Ekici, Arif Bülent http://orcid.org/0000-0001-6099-7066
Buettner, Christian
Habenicht, Katharina Marie
Winkler, Thomas H. http://orcid.org/0000-0002-1860-0528
Krönke, Gerhard http://orcid.org/0000-0002-7566-4325
Schett, Georg http://orcid.org/0000-0001-8740-9615
- License Information
-
More Information
Article History
Received: 4 July 2022
Accepted: 18 August 2022
First Online: 15 September 2022
Competing interests
: There are no competing interests related to this study. The study received no commercial funding. F.M., S.B., A.W., M.A., S.V., D.S., A.K., L.M., S. Kretschmann, S. Kharboutli, R.G., H.R., W.R., S.U., M.H., A.B.E., C.B., K.M.H. and T.W. declare no competing interests. A.M. received speaker honoraria from BMS, Celgene, Gilead, Janssen, KITE, Miltenyi Biomedicine and Novartis, which were not related to this study. G.K. has received speaker honoraria from AbbVie, BMS, Eli Lilly, GSK, Janssen, Novartis and Sanofi. D.M. received speaker honoraria from AbbVie, Amgen, AstraZeneca, BMS, Celgene, Gilead, Hexal, Jazz Pharmaceuticals, Miltenyi Biomedicine, Novartis, Roche and Takeda, which were not related to this study. H.B. is employee of Orgentec and provided quantitative analyses for autoantibodies against nuclear antigens free of charge. G.S. received speaker honoraria from AbbVie, Janssen and Novartis, which were not related to this study.
